S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.28 (-1.64%)
AMD   117.83 (-5.15%)
T   16.10 (+2.74%)
F   13.59 (+5.10%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.26%)
GE   106.08 (+0.59%)
DIS   92.52 (+0.39%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.28 (-1.64%)
AMD   117.83 (-5.15%)
T   16.10 (+2.74%)
F   13.59 (+5.10%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.26%)
GE   106.08 (+0.59%)
DIS   92.52 (+0.39%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.28 (-1.64%)
AMD   117.83 (-5.15%)
T   16.10 (+2.74%)
F   13.59 (+5.10%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.26%)
GE   106.08 (+0.59%)
DIS   92.52 (+0.39%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
S&P 500   4,267.52 (-0.38%)
DOW   33,665.02 (+0.27%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.28 (-1.64%)
AMD   117.83 (-5.15%)
T   16.10 (+2.74%)
F   13.59 (+5.10%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.26%)
GE   106.08 (+0.59%)
DIS   92.52 (+0.39%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NASDAQ:HLVX

HilleVax (HLVX) Stock Forecast, Price & News

$17.94
-0.56 (-3.03%)
(As of 05:40 PM ET)
Compare
Today's Range
$17.32
$18.61
50-Day Range
$12.93
$18.76
52-Week Range
$7.90
$24.42
Volume
76,005 shs
Average Volume
57,042 shs
Market Capitalization
$703.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HilleVax MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
5.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of HilleVax in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.55) to ($3.12) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.76 out of 5 stars


HLVX stock logo

About HilleVax (NASDAQ:HLVX) Stock

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Receive HLVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HilleVax and its competitors with MarketBeat's FREE daily newsletter.

HLVX Stock News Headlines

Save $200 on MarketBeat All Access
MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Claim your $200 account credit and free 30-day trial subscription today.
Stifel Nicolaus Sticks to Its Buy Rating for HilleVax, Inc (HLVX)
Stifel Nicolaus Reaffirms Their Buy Rating on HilleVax, Inc (HLVX)
HilleVax (NASDAQ:HLVX) Sees Strong Trading Volume
Save $200 on MarketBeat All Access
MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Claim your $200 account credit and free 30-day trial subscription today.
J.P. Morgan Keeps Their Buy Rating on HilleVax, Inc (HLVX)
HilleVax: Q1 Earnings Insights
HilleVax (HLVX) & Its Competitors Financial Survey
HilleVax (HLVX) & Its Peers Financial Comparison
HilleVax (HLVX) and Its Peers Financial Contrast
Comparing HilleVax (HLVX) and Its Competitors
HilleVax (HLVX) & Its Peers Head-To-Head Analysis
HilleVax (HLVX) vs. Its Peers Financial Analysis
HilleVax (NASDAQ:HLVX) Stock Price Up 8.8%
See More Headlines

HLVX Price History

HLVX Company Calendar

Last Earnings
5/12/2023
Today
6/07/2023
Next Earnings (Estimated)
8/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HLVX
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Net Income
$-159,810,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$8.01 per share

Miscellaneous

Free Float
27,714,000
Market Cap
$702.86 million
Optionable
Not Optionable
Beta
0.04

Key Executives

  • Dr. Robert M. Hershberg M.D.Dr. Robert M. Hershberg M.D. (Age 61)
    Ph.D., Pres, CEO & Chairman
    Comp: $611.2k
  • Mr. David A. SocksMr. David A. Socks (Age 48)
    CFO & Chief Bus. Officer
    Comp: $561.72k
  • Mr. Aditya Kohli Ph.D. (Age 35)
    COO & Director
    Comp: $576.55k
  • Dr. Anju Chatterji Ph.D.
    Sr. VP of Technical Operations
  • Mr. Paul S. Bavier J.D. (Age 51)
    Gen. Counsel, Sec. & Chief Admin. Officer
  • Ms. Astrid Borkowski M.D. (Age 53)
    Ph.D., Chief Medical Officer
  • Ms. Kaia Agarwal
    Sr. VP of Regulatory Affairs













HLVX Stock - Frequently Asked Questions

How have HLVX shares performed in 2023?

HilleVax's stock was trading at $16.73 on January 1st, 2023. Since then, HLVX stock has increased by 7.2% and is now trading at $17.93.
View the best growth stocks for 2023 here
.

When is HilleVax's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our HLVX earnings forecast
.

How were HilleVax's earnings last quarter?

HilleVax, Inc. (NASDAQ:HLVX) released its quarterly earnings results on Friday, May, 12th. The company reported ($0.71) earnings per share for the quarter, beating analysts' consensus estimates of ($0.96) by $0.25.

What ETFs hold HilleVax's stock?
When did HilleVax IPO?

(HLVX) raised $200 million in an initial public offering on Friday, April 29th 2022. The company issued 11,765,000 shares at $16.00-$18.00 per share.

What is HilleVax's stock symbol?

HilleVax trades on the NASDAQ under the ticker symbol "HLVX."

Who are HilleVax's major shareholders?

HilleVax's stock is owned by many different institutional and retail investors. Top institutional investors include Carlyle Group Inc. (4.69%), Franklin Resources Inc. (3.28%), BlackRock Inc. (2.65%), Geode Capital Management LLC (0.73%), State Street Corp (0.70%) and Fred Alger Management LLC (0.22%).

How do I buy shares of HilleVax?

Shares of HLVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HilleVax's stock price today?

One share of HLVX stock can currently be purchased for approximately $17.93.

How much money does HilleVax make?

HilleVax (NASDAQ:HLVX) has a market capitalization of $702.86 million. The company earns $-159,810,000.00 in net income (profit) each year or ($3.75) on an earnings per share basis.

How can I contact HilleVax?

The official website for the company is www.hillevax.com. The company can be reached via phone at 617-213-5054 or via email at ir@hillevax.com.

This page (NASDAQ:HLVX) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -